日本新薬
4516
東証プライム
医薬品
日本新薬の決算推移
損益計算書
(単位:百万円)
2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
---|---|---|---|---|---|---|---|---|---|---|---|
売上高 | 76,517 | 79,991 | 84,209 | 98,781 | 101,448 | 114,716 | 116,637 | 121,885 | 137,484 | 144,175 | 148,255 |
売上原価 | 39,033 | 41,226 | 44,016 | 44,835 | 46,929 | 50,952 | 53,155 | 49,954 | 50,191 | 55,980 | 50,234 |
売上総利益 | 37,483 | 38,764 | 40,192 | 53,946 | 54,519 | 63,764 | 63,481 | 71,931 | 87,293 | 88,195 | 98,021 |
販管費 | 29,445 | 30,202 | 31,643 | 38,666 | 37,439 | 43,119 | 41,813 | 45,796 | 32,173 | 34,812 | 34,959 |
営業利益 | 8,038 | 8,562 | 8,549 | 15,280 | 17,079 | 20,644 | 21,668 | 26,134 | 32,948 | 30,049 | 33,295 |
営業外収益 | 1,019 | 939 | 1,246 | 1,587 | 1,122 | 1,435 | 1,599 | 1,326 | N/A | N/A | N/A |
営業外費用 | 460 | 573 | 842 | 623 | 751 | 539 | 824 | 701 | N/A | N/A | N/A |
経常利益 | 8,598 | 8,928 | 8,952 | 16,244 | 17,451 | 21,540 | 22,442 | 26,760 | N/A | N/A | N/A |
特別利益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1,998 | N/A | N/A | N/A |
特別損失 | N/A | N/A | N/A | 766 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | 5,750 | 5,882 | 6,340 | 11,749 | 12,953 | 16,302 | 16,866 | 20,702 | 24,986 | 22,812 | 25,851 |
貸借対照表
(単位:百万円)
2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
---|---|---|---|---|---|---|---|---|---|---|---|
資産 | 118,188 | 129,757 | 135,370 | 150,905 | 158,192 | 168,763 | 175,017 | 197,028 | 219,943 | 237,451 | 263,404 |
流動資産 | 74,683 | 80,422 | 85,401 | 98,787 | 97,953 | 110,720 | 121,925 | 139,090 | 149,724 | 157,873 | 164,285 |
現金及び預金 | 11,097 | 11,841 | 20,435 | 30,781 | 21,067 | 31,519 | 36,005 | 47,770 | 60,566 | 60,047 | 58,094 |
売上債権 | 34,137 | 35,010 | 35,135 | 36,444 | 39,593 | 45,982 | 40,947 | 39,289 | 43,178 | 44,686 | 47,237 |
棚卸資産 | 15,732 | 19,657 | 18,927 | 18,574 | 20,345 | 19,371 | 29,893 | 35,523 | 38,066 | 36,358 | 39,111 |
固定資産 | 43,504 | 49,334 | 49,968 | 52,118 | 60,238 | 58,042 | 53,091 | 57,937 | 70,219 | 79,578 | 99,119 |
負債 | 25,002 | 28,550 | 32,607 | 36,589 | 32,503 | 33,572 | 29,256 | 34,485 | 39,057 | 41,518 | 42,870 |
流動負債 | 15,257 | 17,770 | 20,569 | 27,001 | 22,454 | 25,406 | 24,965 | 31,514 | 32,029 | 35,183 | 37,336 |
仕入債務 | 6,099 | 7,118 | 6,759 | 6,232 | 8,639 | 7,986 | 11,213 | 9,543 | 21,022 | 20,538 | 24,706 |
固定負債 | 9,744 | 10,779 | 12,037 | 9,587 | 10,048 | 8,165 | 4,290 | 2,970 | 7,027 | 6,334 | 5,533 |
純資産 | 93,186 | 101,207 | 102,762 | 114,316 | 125,689 | 135,190 | 145,760 | 162,543 | 180,886 | 195,933 | 220,534 |
利益剰余金 | 81,105 | 85,137 | 89,658 | 99,897 | 109,078 | 121,677 | 132,886 | 147,391 | 165,303 | 180,433 | 198,260 |
自己株式 | -2,175 | -2,327 | -2,413 | -2,450 | -2,464 | -2,469 | -2,473 | -2,476 | -2,478 | -2,480 | -2,480 |
キャッシュフロー計算書
(単位:百万円)
2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
---|---|---|---|---|---|---|---|---|---|---|---|
営業CF | 6,015 | 6,113 | 8,915 | 18,916 | 6,719 | 15,310 | 12,737 | 21,388 | 21,316 | 26,170 | 16,289 |
投資CF | -3,357 | -3,718 | -3,978 | -5,750 | -11,342 | 511 | -2,339 | -1,564 | -10,037 | -17,631 | -9,921 |
財務CF | -1,606 | -1,773 | -1,907 | -2,193 | -3,787 | -3,708 | -5,660 | -6,199 | -8,407 | -9,605 | -9,719 |
フリーCF | 2,658 | 2,395 | 4,937 | 13,166 | -4,623 | 15,821 | 10,398 | 19,824 | 11,279 | 8,539 | 6,368 |